COMMUNIQUÉS West-GlobeNewswire

LIDDS employs Head of Business Development

10/01/2019 - 11:12

LIDDS announces today that Markus Thor has been appointed as Head of Business Development and will join the company in March 2019. The employment is a consequence of the enlarged project portfolio and the broad interest [...]

Completion of $25 million Subscription

10/01/2019 - 08:00

Summit Therapeutics plc (“Summit Therapeutics” or the “Company”) Completion of $25 million subscription Oxford, UK, and Cambridge, MA, US, 10 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a leader in [...]

First Asian patient has been included in the global Phase III program for PledOx® and will trigger a milestone payment of 600 MJPY (c.49 MSEK) to PledPharma

10/01/2019 - 08:00

Stockholm, January 10, 2019. PledPharma AB (publ) and Solasia Pharma K.K. announces that the first patient has been included in the global Phase III program for the drug candidate PledOx ® in Japan. This constitutes an [...]

ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today

10/01/2019 - 07:18

Amsterdam, The Netherlands - 10 January 2019 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 24 th Tranche of EUR 230,000 is issued as a private placement of 23 convertible notes (the " [...]

Innate Pharma announces its financial calendar for 2019

10/01/2019 - 07:00

INNATE PHARMA ANNOUNCES ITS FINANCIAL CALENDAR FOR 2019 Marseille, France, January 10, 2019, 7:00 AM CET Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces its financial calendar for [...]

Innate Pharma annonce son calendrier financier pour 2019

10/01/2019 - 07:00

INNATE PHARMA ANNONCE SON CALENDRIER FINANCIER POUR 2019 Marseille, le 10 janvier 2019, 7h00 CET Innate Pharma SA (la « Société », Euronext Paris : FR0010331421 – IPH) annonce aujourd’hui son calendrier financier pour l [...]

Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock

10/01/2019 - 05:20

RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]

New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi® (caplacizumab) for rare blood clotting disorder

09/01/2019 - 23:01

New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi ® (caplacizumab) for rare blood clotting disorder HERCULES Phase 3 trial met its primary endpoint, demonstrating that treatment [...]

Le New England Journal of Medicine publie les résultats positifs de l'essai pivot du Cablivi® (caplacizumab) dans le traitement d'un trouble rare de la coagulation sanguine

09/01/2019 - 23:01

Le New England Journal of Medicine publie les résultats positifs de l'essai pivot du Cablivi ® (caplacizumab) dans le traitement d'un trouble rare de la coagulation sanguine L'essai HERCULES de phase III a atteint son [...]

DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange

09/01/2019 - 23:00

MINNEAPOLIS, Jan. 09, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) (TSX-V: DMA), a clinical stage biopharmaceutical company, announced today that it has applied to voluntarily delist its voting [...]

Imagin Medical Posts New Presentation on Its Website

09/01/2019 - 22:30

VANCOUVER, British Columbia and BOSTON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that, ahead of its [...]

Loop Industries Reports Third Quarter of Fiscal 2019 Consolidated Results and Achieves Significant Milestones as It Approaches Commercialization

09/01/2019 - 22:15

Announced multi-year supply agreement with PepsiCo Inc. Announced multi-year supply framework with Coca-Cola system’s Cross Enterprise Procurement Group Announced joint venture with Indorama Ventures Public Company [...]

Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock

09/01/2019 - 22:00

RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]

Nature Medicine Publishes Local and International Companies’ Major Data Analytics Study of Type 2 Diabetes

09/01/2019 - 21:59

Findings are the result of a year-long collaboration of Roche Diabetes Care GmbH, IBM, Eli Lilly and Company, the Regenstrief Institute and the Indiana Bioscience Research Institute INDIANAPOLIS, Jan. 09, 2019 (GLOBE [...]

UPDATED RELEASE: Rafael Pharmaceuticals Announces Initiation of Patient Enrollment for Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia

09/01/2019 - 19:15

This release was originally published on January 8th. The updated release makes note that the trial will be led by Ariella Noy, MD at Memorial Sloan Kettering. Newark, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Rafael [...]

UPDATE -- Dr. Jeffrey D. Gross of Newport Beach, CA Now Offering Virtual Second Opinion Consultations for Surgery

09/01/2019 - 17:53

NEWPORT BEACH, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Dr. Jeffrey D. Gross, a board-certified neurological surgeon, today announced he is now offering comprehensive second opinion consultations for patients [...]

Holding(s) in Company

09/01/2019 - 17:45

TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]

Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare

09/01/2019 - 17:01

Program Celebrates the Legacy of Medtronic Co-Founder Earl Bakken and Other Outstanding Patient Advocates Around the World MINNEAPOLIS and Kona, Hawaii - January 9, 2019 - The Medtronic Foundation today announced 12 [...]

Results-Based Outsourcing Inc., Announces Name Change to Driven Inc.

09/01/2019 - 16:45

Company provides update on Capitalization Structure SAN DIEGO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Results Based Outsourcing Inc. (RBOS) today announced that it has received approval for plans to change the corporate name [...]